| Oct 18 |
Discover October 2024's Stocks Estimated To Be Trading Below Fair Value
|
| Oct 18 |
Novo Nordisk A/S: Alhemo® recommended for European approval as first once-daily subcutaneous prophylactic treatment for people living with haemophilia A or B with inhibitors
|
| Oct 18 |
Jim Cramer Says Novo Nordisk A/S (NVO) ‘Doesn’t Hold A Candle To Eli Lilly’
|
| Oct 17 |
Consumer groups ask FTC to block Novo Holdings-Catalent deal
|
| Oct 17 |
Ozempic and other weight loss drugs could help treat alcohol and drug addiction, study says
|
| Oct 17 |
Investors must 'be wary' how interest rates impact this market: Strategist
|
| Oct 17 |
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR
|
| Oct 17 |
Novo Nordisk A/S (NVO): Most Promising Future Stock According to Analysts
|
| Oct 16 |
Is Novo Nordisk A/S (NVO) the Most Promising Biotech Stock According to Hedge Funds?
|
| Oct 16 |
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win
|
